Literature DB >> 4146575

Inhibition by gamma-hydroxybutyrate of chlorpromazine-induced increase in homovanillic acid.

R H Roth.   

Abstract

1. gamma-Hydroxybutyrate and its lactone precursor, gamma-butyrolactone, when administered in anaesthetic doses block the increase in the cerebral concentration of homovanillic acid normally observed after administration of chlorpromazine or haloperidol.2. Other hypnotics such as glutethimide, urethane, chloralose, chloral hydrate and thiopentone do not have this ability even when administered in anaesthetic doses.3. The ability of gamma-hydroxybutyrate to block the neuroleptic-induced increase in cerebral homovanillic acid is not due to a reduction in body temperature since a similar effect is observed in rats treated under conditions (32 degrees C) in which body temperature remains normal.4. Possible mechanisms for this action of gamma-hydroxybutyrate are discussed.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4146575      PMCID: PMC1776541          DOI: 10.1111/j.1476-5381.1973.tb08338.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.

Authors:  R LAVERTY; D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1965-06

2.  Tropolones: a unique class of potent non-competitive inhibitors of S-adenosylmethionine-catechol methyltransferase.

Authors:  B BELLEAU; J BURBA
Journal:  Biochim Biophys Acta       Date:  1961-11-25

3.  Effect of anesthetic doses of hydroxybutyrate on subcortical concentrations of homovanillic acid.

Authors:  R H Roth
Journal:  Eur J Pharmacol       Date:  1971-06       Impact factor: 4.432

4.  Selective increase of brain dopamine induced by gamma-hydroxybutyrate: study of the mechanism of action.

Authors:  G L Gessa; F Crabai; L Yargiu; P F Spano
Journal:  J Neurochem       Date:  1968-05       Impact factor: 5.372

5.  Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain.

Authors:  H Nybäck; G Sedvall
Journal:  J Pharmacol Exp Ther       Date:  1968-08       Impact factor: 4.030

6.  Gamma-hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy.

Authors:  G K Aghajanian; R H Roth
Journal:  J Pharmacol Exp Ther       Date:  1970-10       Impact factor: 4.030

7.  Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep".

Authors:  R H Roth; Y Suhr
Journal:  Biochem Pharmacol       Date:  1970-12       Impact factor: 5.858

8.  Some neurochemical aspects of the depressant action of gamma-butyrolactone on the central nervous system.

Authors:  N J GIARMAN; K F SCHMIDT
Journal:  Br J Pharmacol Chemother       Date:  1963-06

9.  Effect of -hydroxybutyrate on the release of monoamines from the rat striatum.

Authors:  G Bustos; R H Roth
Journal:  Br J Pharmacol       Date:  1972-04       Impact factor: 8.739

10.  Release of monoamines from the striatum and hypothalamus: effect of -hydroxybutyrate.

Authors:  G Bustos; R H Roth
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

View more
  4 in total

1.  On the interaction of 5-hydroxytryptophan and 5-hydroxytryptamine with dopamine metabolism in the rat striatum.

Authors:  N Awazi; H C Guldberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

2.  The regulation of striatal tyrosine hydroxylase. Effects of gamma hydroxybutric acid and healperidol.

Authors:  B Zivkovic; A Guidotti; E Costa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  Effect of anaesthetic agents on the synthesis and disappearance of brain dopamine normally and after haloperidol, Kcl or axotomy.

Authors:  N E Andén; T Magnusson; G Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Increase in mouse brain dopamine content by baclofen: effects of apomorphine and neuroleptics.

Authors:  G Gianutsos; K E Moore
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.